We are taking a 360-degree approach to developing rational combination therapies that address large unmet medical needs.

During his career, he played critical roles in advancing 15 small molecule candidates into the clinic.

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. ... Unlock Charts on Crunchbase .

Apr 4, … Charts can be found on various organization profiles and on Hubs pages, based on data availability. Terns is developing a pipeline of novel therapies that target chronic liver diseases such as non-alcoholic steatohepatitis (NASH), liver fibrosis and hepatocellular carcinoma. TERNS - US 1065 East Hillsdale, Suite 100 Foster City, CA 94404 ()info@ternspharma.com Fax: +1 650-275-4395 TERNS - CHINA Changning Raffles City Tower 2, #1189 Changning Road

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. Dr. Halcomb brings over 20 years of experience in biopharma and academic life sciences. Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.

CREATE ALERTS ... Terns Pharmaceuticals .

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. Series A. Unlock the full power of the Crunchbase Platform with Crunchbase Pro! He previously served as a Director of Medicinal Chemistry at Gilead Sciences where he led programs spanning multiple phases of discovery, from early development and high-throughput … Weidong Zhong is the CEO and co-founder of Terns Pharmaceuticals.

$30,000,000. Try Pro free Solutions Products Resources Pricing Log In List of Terns Pharmaceuticals 's 2 Funding Rounds from 4 Investors.

The hot NASH arena has a new player, Terns Pharmaceuticals, and it has already got three candidates from Eli Lilly, a $30 million series A backed by Lilly Asia Ventures, and a … The Company discovers and develops molecularly-targeted and oral molecule drugs for the treatment of liver disease and cancer. Randall Halcomb is Senior Vice President of Chemistry and Early Development and co-founder of Terns Pharmaceuticals. Biotech-Careers. payment from Terns Pharmaceuticals and we finished 2019 with a cash position of €277MM. Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), was a pharmaceutical company.

Biotech-Careers. Associated sectors: Small Molecule Pharmaceuticals; Small Molecules; Similar Companies: